AURIGENE DISCOVERY TECHNOLOGIES LTD

Aurigene Discovery Technologies Ltd. is a research and development service provider, specifically a Contract Research Organization (CRO). It is not a factory and it is not a trader.

Aurigene Discovery Technologies Ltd. is an India-based biotechnology company focused on the discovery and development of novel small molecule and peptide drugs. As a subsidiary of Dr. Reddy's Laboratories, Aurigene leverages its expertise in integrated drug discovery services to bring innovative therapies to patients. The company specializes in various therapeutic areas, including oncology, inflammation, and immunology.

Aurigene offers comprehensive services spanning the entire drug discovery process, from target identification and validation to lead optimization, preclinical development, and support for clinical trials. Their capabilities include medicinal chemistry, in vitro and in vivo biology, pharmacology, ADME (Absorption, Distribution, Metabolism, Excretion), toxicology, and CMC (Chemistry, Manufacturing, and Controls) support. Aurigene partners with pharmaceutical and biotechnology companies worldwide, providing a robust platform for advancing drug candidates through early-stage development. Their business model is centered on intellectual property creation and licensing, as well as providing discovery research services.

Aurigene Discovery Technologies Ltd. focuses on drug discovery and development services, primarily in the areas of:

* Oncology

* Inflammation

They offer services like:

* Target discovery

* Drug discovery

* Preclinical development